AstraZeneca CEO Considers Shifting Stock Listing to US
Pascal Soriot, the chief executive of AstraZeneca, has reportedly expressed interest in moving the company’s stock market listing from the UK to the US.
The head of Britain’s most valuable listed firm has privately discussed favoring a shift to New York, according to the Times, which also noted that he had weighed relocating the company’s legal headquarters.
AstraZeneca’s shares rose 2.8% on Tuesday, with much of the gain occurring after the report was published.
Such a move would be a significant setback for the London Stock Exchange, which has already seen several major companies leave in pursuit of higher valuations. Recent departures from the FTSE 100 include equipment rental firm Ashtead, betting company Flutter Entertainment, construction supplier CRH, and packaging business Smurfit Westrock.
While the UK government would likely oppose AstraZeneca’s relocation, it lacks the authority to prevent it. Labour recently identified life sciences as a priority sector in its industrial strategy.
AstraZeneca declined to comment.
The company is believed to have privately voiced dissatisfaction after the NHS refused to fund its breast cancer drug, Enhertu, due to cost concerns. Earlier this year, the Cambridge-based firm withdrew from a £450m vaccine project in Liverpool, citing insufficient government financial backing.
Since Soriot became CEO in 2012, AstraZeneca’s market value has more than tripled. It now exceeds that of Shell – also rumored to be considering a US move – and HSBC, reaching £157bn.
The US remains the largest pharmaceutical market globally, with the highest per-capita drug spending, despite shorter life expectancies than some nations. UK executives often argue their firms are undervalued compared to US peers.
Soriot has highlighted ambitions to expand in the US. Last November, he told investors the company aims for further growth there as part of its 2030 strategy, according to data firm Alphasense. He described the US as a critical market that fosters innovation, vowing continued investment to accelerate expansion.
Read next
Abuse survivors of Mohamed Al Fayed demand investigation into human trafficking
Survivors of abuse by former Harrods owner Mohamed Al Fayed are demanding a comprehensive investigation into human trafficking, asserting that such an inquiry is necessary to uncover the full extent of the billionaire’s alleged network.
The collective No One Above (NOA), established by victims of Fayed, is urging the
Climate activists criticize Shell for profiting from Iran conflict windfall
Shell announced stronger‑than‑anticipated earnings of $6.9 billion (£5 billion) after its oil‑trading arm profited from surging energy prices amid the Iran conflict, drawing criticism from climate activists.
Rising oil and gas prices during the Middle East turmoil enabled Europe’s largest oil and gas producer to
Jet Fuel Shortage Could Ground Travel, Reshape Vacations and History
What would happen to flights if the world exhausted its oil supply? Clearly, they would be grounded. More pointedly, could airlines simply run out of aviation fuel if the Iran conflict persists and the Strait of Hormuz stays closed?
This question has never arisen before. Air travel has faced unexpected